Effects of the Consumption of a Supplement Rich in Docosahexaenoic Acid (DHA) From Algae
NCT ID: NCT04278482
Last Updated: 2023-01-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
102 participants
INTERVENTIONAL
2020-03-10
2021-07-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In this regard, validation of supplements rich in the n-3 fatty acid DHA that are not obtained from fish is needed, thus the study will test the bioavailability and metabolic effects of a DHA supplement form algae.
The study will be conducted on the effects of the DHA supplement versus placebo in vegetarian and non-vegetarian healthy adults.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Docosahexaenoic and Eicosapentaenoic Acids in Hypercholesterolemic Children Plus Diet on Docosahexaenoic Acid (DHA) Status
NCT00678067
Effects of Docosahexaenoic Acid (DHA) on Cognitive Function in Children 4 Years of Age
NCT00351624
Effects of Omega-3 Fatty Acids Supplementation on Brain and Behaviour in Healthy Children.
NCT02346773
Omega-3 Fatty Acids and/or Multi-domain Intervention in the Prevention of Age-related Cognitive Decline
NCT00672685
Dietary Supplement for the Prevention of Cognitive Decline in a Very Elderly Population.
NCT01817101
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DHA supplement
Supplement rich in DHA form algae source
Dietary supplement, DHA or Placebo
Consumption of 2 capsules per day of the dietary supplement, DHA or Placebo
Placebo
Placebo supplement
Dietary supplement, DHA or Placebo
Consumption of 2 capsules per day of the dietary supplement, DHA or Placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dietary supplement, DHA or Placebo
Consumption of 2 capsules per day of the dietary supplement, DHA or Placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy.
* Women.
* Men.
* Participant following either a vegetarian diet during at least 6 months or following a omnivorous diet but consuming fish 2 times per week or less.
Exclusion Criteria
* Pregnancy.
* Diseases: liver diseases, gastric diseases, irritable bowel, hypercholesterolemia, hypertension, diabetes, biliary colic.
* Having participated in a clinical study in the last 3 months.
* Eating disorders.
* Consumption of foods fortified with omega-3 fatty acids in the last 3 months.
* Consumption of supplements of omega-3 fatty acids in the last 3 months.
* Participant who have followed either a vegetarian diet for less than six months or an omnivorous diet including fish more than 2 times per week.
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Comunidad de Madrid
OTHER
National Research Council, Spain
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
M Pilar Vaquero
Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
M.Pilar Vaquero, Dr
Role: PRINCIPAL_INVESTIGATOR
CSIC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
M.Pilar Vaquero
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Garcia-Maldonado E, Alcorta A, Zapatera B, Vaquero MP. Changes in fatty acid levels after consumption of a novel docosahexaenoic supplement from algae: a crossover randomized controlled trial in omnivorous, lacto-ovo vegetarians and vegans. Eur J Nutr. 2023 Jun;62(4):1691-1705. doi: 10.1007/s00394-022-03050-3. Epub 2022 Nov 23.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IND2018/BIO-9554
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.